Paulo S V Naud1, Richard Muwonge2, Eduardo P Passos1, Valentino Magno3, Jean Matos4, Rengaswamy Sankaranarayanan5. 1. Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil; Federal University of Rio Grande do Sul, Porto Alegre, Brazil. 2. Screening Group, Early Detection and Prevention Section, International Agency for Research on Cancer, Lyon, France. 3. Federal University of Rio Grande do Sul, Porto Alegre, Brazil. 4. Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil. 5. Screening Group, Early Detection and Prevention Section, International Agency for Research on Cancer, Lyon, France. Electronic address: sankarr@iarc.fr.
Abstract
OBJECTIVE: To analyze the acceptability, safety, and effectiveness of thermocoagulation for the treatment of histologically proven cervical intraepithelial neoplasia grade 2-3 (CIN2-3) lesions. METHODS: In a retrospective study, data were obtained for women treated for CIN2-3 lesions by thermocoagulation at the Hospital de Clínicas de Porto Alegre, Brazil, between March 6, 2012, and October 29, 2013, and followed up after 1 year. The proportions of women with no evidence of disease, adverse effects, or complications were determined. RESULTS: Among 52 women included, 44 (85%) had no evidence of disease 1year after thermocoagulation. The rate of no disease at follow-up was similar for women treated for CIN2 (17/20 [85%]) and CIN3 (27/32 [84%]). No serious adverse effects or complications requiring hospitalization were observed during the follow-up period. CONCLUSION: Thermocoagulation is useful in the management of ectocervical CIN and should be integrated into public health services for management of cervical cancer.
OBJECTIVE: To analyze the acceptability, safety, and effectiveness of thermocoagulation for the treatment of histologically proven cervical intraepithelial neoplasia grade 2-3 (CIN2-3) lesions. METHODS: In a retrospective study, data were obtained for women treated for CIN2-3 lesions by thermocoagulation at the Hospital de Clínicas de Porto Alegre, Brazil, between March 6, 2012, and October 29, 2013, and followed up after 1 year. The proportions of women with no evidence of disease, adverse effects, or complications were determined. RESULTS: Among 52 women included, 44 (85%) had no evidence of disease 1year after thermocoagulation. The rate of no disease at follow-up was similar for women treated for CIN2 (17/20 [85%]) and CIN3 (27/32 [84%]). No serious adverse effects or complications requiring hospitalization were observed during the follow-up period. CONCLUSION: Thermocoagulation is useful in the management of ectocervical CIN and should be integrated into public health services for management of cervical cancer.
Authors: Karen Haney; Pushpa Tandon; Rao Divi; Miguel R Ossandon; Houston Baker; Paul C Pearlman Journal: IEEE J Transl Eng Health Med Date: 2017-11-23 Impact factor: 3.316
Authors: Phuong Lien Tran; Bruno Kenfack; Eveline Tincho Foguem; Manuela Viviano; Liliane Temogne; Pierre-Marie Tebeu; Rosa Catarino; Anne-Caroline Benski; Pierre Vassilakos; Patrick Petignat Journal: Int J Womens Health Date: 2017-12-01
Authors: Dipanwita Banerjee; Ranajit Mandal; Amit Mandal; Ishita Ghosh; Srabani Mittal; Richard Muwonge; Eric Lucas; Partha Basu Journal: Asian Pac J Cancer Prev Date: 2020-05-01
Authors: Michelle B Shin; Gui Liu; Nelly Mugo; Patricia J Garcia; Darcy W Rao; Cara J Bayer; Linda O Eckert; Leeya F Pinder; Judith N Wasserheit; Ruanne V Barnabas Journal: Front Public Health Date: 2021-07-01
Authors: Manuel Sandoval; Rose Slavkovsky; Pooja Bansil; Jose Jeronimo; Jeanette Lim; Jacqueline Figueroa; Silvia de Sanjose Journal: Trop Med Int Health Date: 2019-11-21 Impact factor: 2.622